×

Register now for full access to all the content

First Name
Last Name
Company
Title
Country
Thank you for registering!
Error - something went wrong!

PAREXEL - Josef von Rickenbach speaks about the importance of the Japanese pharmaceutical market

November 12, 2014
Japan's pharmaceutical market is one of the most important pharmaceutical markets in the world. It has a vibrant research based industry based in Japan. Many of these companies are conducting clinical trials which support approvals, eventually, in Japan. Also, many of these companies are attempting to get approvals for their products outside of Japan. We are supporting them with those efforts. Conversely, many western companies are attempting to get their products registered in Japan and we are also working with those companies, helping them get their products on the market here and making their products available to patients here. We are very proud of our rebranding and our new market presentation. The slogan "Your Journey. Our Mission." summarizes our philosophy on how we approach our marketplace. Our clients often have an arduous task in front of them to try to get approval for products. It is PAREXEL's job to help them with that with all of our might and all of our efforts. We have no conflict of any sort. We have a complete focus in making sure that that journey from the original molecule in the laboratory to the patient is as simple and as painless as possible for our client.
Previous Video
PAREXEL - New European Coordination Hub and Distribution Center in Schönefeld (Berlin), Germany
PAREXEL - New European Coordination Hub and Distribution Center in Schönefeld (Berlin), Germany

PAREXEL’s new world-class European Coordination Hub and Distribution Center in Schönefeld, Germany is commi...

Next Video
PAREXEL - Thomas Senderovitz speaks about PAREXEL's global capabilities
PAREXEL - Thomas Senderovitz speaks about PAREXEL's global capabilities

We are clearly seeing an increased focus on early patient access. It seems very clear to us that studies in...